Key facts
- BrightSpec Labs’s last known valuation is $36.0M (May 2025).
- It has raised $32.2M; the latest was Later Stage VC ($22.3M) in May 2025.
- Notable investors include US National Science Foundation, United States Department of War, Arboretum Ventures, CAV Angels, Genoa Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for BrightSpec Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for BrightSpec Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrightSpec Labs
Developer of a molecular rotational resonance spectroscopy platform designed for analytical chemistry. The company's platform provides full characterization of molecules and is sensitive enough to distinguish between stereoisomers as well as isotopes, with the potential to transform the relationship between artificial intelligence and sample analytics given that molecular rotational resonance spectra by using quantum theory and allow for the development of methods without the need for reference samples or separations, enabling chemical manufacturers to analyze complex mixtures without the need for chromatography.
- Sector
- Information Technology
- HQ
- Charlottesville, VA, United States
- Founded
- 2012
- Employees
- 29
- Website
- brightspec.com/
- Ownership
- Privately Held (backing)
BrightSpec Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrightSpec Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrightSpec Labs in its N-PORT filings yet. We sweep new filings monthly.